These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10841067)

  • 1. [Rheumatic disorders. Overview].
    Fautrel B; Bourgeois P
    Drugs; 2000; 59 Spec No 1():1-9. PubMed ID: 10841067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis: a prospective 13 year study of 2131 patients.
    Wolfe F; Hawley DJ
    J Rheumatol; 2000 Jul; 27(7):1668-73. PubMed ID: 10914849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases.
    Denko CW; Malemud CJ
    Semin Arthritis Rheum; 2005 Aug; 35(1):24-34. PubMed ID: 16084221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: results of 2 randomized double-blind controlled trials.
    Biegert C; Wagner I; Lüdtke R; Kötter I; Lohmüller C; Günaydin I; Taxis K; Heide L
    J Rheumatol; 2004 Nov; 31(11):2121-30. PubMed ID: 15517622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonal symptom severity in patients with rheumatic diseases: a study of 1,424 patients.
    Hawley DJ; Wolfe F; Lue FA; Moldofsky H
    J Rheumatol; 2001 Aug; 28(8):1900-9. PubMed ID: 11508598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatigue, rheumatoid arthritis, and anti-tumor necrosis factor therapy: an investigation in 24,831 patients.
    Wolfe F; Michaud K
    J Rheumatol; 2004 Nov; 31(11):2115-20. PubMed ID: 15517621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jaw pain: its prevalence and meaning in patients with rheumatoid arthritis, osteoarthritis, and fibromyalgia.
    Wolfe F; Katz RS; Michaud K
    J Rheumatol; 2005 Dec; 32(12):2421-8. PubMed ID: 16331775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor inhibitors: risks and benefits in patients with rheumatoid arthritis.
    Roberts L; McColl GJ
    Intern Med J; 2004 Dec; 34(12):687-93. PubMed ID: 15610214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokinin panel in rheumatoid arthritis and correlation with histological patterns of synovitis -- active type of disease.
    Avrămescu C; Vere CC; Mărgăritescu C; Turculeanu A; Bălăşoiu M; Rogoz S
    Rom J Morphol Embryol; 2005; 46(2):87-92. PubMed ID: 16286991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the NSAID nimesulide on the radical scavenger glutathione S-transferase in patients with osteoarthritis of the knee.
    Kullich W; Fagerer N; Schwann H
    Curr Med Res Opin; 2007 Aug; 23(8):1981-6. PubMed ID: 17631696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F; Siddiqui AA
    Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population.
    Ollendorf DA; Peterson AN; Doyle J; Huse DM
    Am J Manag Care; 2002 May; 8(7 Suppl):S203-13. PubMed ID: 12022236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
    Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA
    Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pain in osteoarthritis.
    Pavelka K
    Eur J Pain; 2000; 4 Suppl A():23-30. PubMed ID: 11310479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
    Christodoulou C; Choy EH
    Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher prevalence of gastrointestinal symptoms among patients with rheumatic disorders.
    Chong VH; Wang CL
    Singapore Med J; 2008 May; 49(5):419-24. PubMed ID: 18465055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CD40 expression on articular chondrocytes from patients with rheumatoid arthritis: contribution to production of cytokines and matrix metalloproteinases.
    Gotoh H; Kawaguchi Y; Harigai M; Hara M; Saito S; Yamaguchi T; Shimada K; Kawamoto M; Tomatsu T; Kamatani N
    J Rheumatol; 2004 Aug; 31(8):1506-12. PubMed ID: 15290728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.